Gargoyle Investment Advisor’s PDL BioPharma, Inc. PDLI Stock Holding History

Gargoyle Investment Advisor’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-64,473	Closed	-$324K	–	194
2015 Q3	$324K	Hold	64,473	–	–	0.13%	156
2015 Q2	$415K	Hold	64,473	–	–	0.16%	154
2015 Q1	$454K	Hold	64,473	–	–	0.17%	140
2014 Q4	$497K	Hold	64,473	–	–	0.18%	127
2014 Q3	$482K	Hold	64,473	–	–	0.18%	119
2014 Q2	$624K	Hold	64,473	–	–	0.23%	109
2014 Q1	$536K	Buy	64,473 +6,251	+11%	+$53.6K	0.24%	94
2013 Q4	$491K	Sell	58,222 -8,439	-13%	-$71.1K	0.23%	100
2013 Q3	$531K	Sell	66,661 -1,921	-3%	-$15.4K	0.33%	81
2013 Q2	$529K	Buy	+68,582	New	+$535K	0.27%	80

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return